Syndax Pharmaceuticals, Inc.
USD18.39
-0.46 (-2.44%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.67
Prev. Close
$18.85
Day Low
$18.20
Day High
$19.00
52W Low
$8.59
52W High
$25.59
Market Cap
$1.63B
Volume
1.34M
| 3,410 |
| $21.03 |
| 6 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | Acquired | 73,000 | $0.00 |
| 6 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | Acquired | 144,600 | $0.00 |
| 6 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | S-Sale | Disposed | 7,412 | $20.62 |
| 6 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | Acquired | 440,000 | $20.43 |
| 6 Feb 2026 | Goldan Keith A. | Chief Financial Officer | A-Award | Acquired | 30,750 | $0.00 |
| 6 Feb 2026 | Goldan Keith A. | Chief Financial Officer | S-Sale | Disposed | 2,082 | $20.62 |
| 6 Feb 2026 | Goldan Keith A. | Chief Financial Officer | A-Award | Acquired | 118,000 | $20.43 |
| 6 Feb 2026 | Goldan Keith A. | Chief Financial Officer | A-Award | Acquired | 21,500 | $0.00 |